ORIGINAL RESEARCH
Published on 06 Feb 2025
In vitro anticancer effects of frankincense and its nanoemulsions for enhanced cancer cell targeting
doi 10.3389/fphar.2025.1403780
- 958 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Tackling Breast, Brain, Lung and Ovarian Cancer with Nanomediated Delivery Systems: New Horizons in Cancer Treatment
Tackling Breast, Brain, Lung and Ovarian Cancer with Nanomediated Delivery Systems: New Horizons in Cancer Treatment
3,534
Total downloads
12k
Total views and downloads
Articles
REVIEW
Published on 03 Dec 2024
Enhancing cancer therapy: advanced nanovehicle delivery systems for oridonin
doi 10.3389/fphar.2024.1476739
- 687 views
- 1 citation
ORIGINAL RESEARCH
Published on 19 Nov 2024
Impact of camel milk lactoferrin peptides against breast cancer cells: in silico and in vitro study
doi 10.3389/fphar.2024.1425504
- 1,382 views
- 1 citation
REVIEW
Published on 14 Oct 2024
Nanomedicine in HNSCC therapy-a challenge to conventional therapy
doi 10.3389/fphar.2024.1434994
- 1,097 views
- 1 citation
SYSTEMATIC REVIEW
Published on 12 Jul 2024
Trend of albumin nanoparticles in oncology: a bibliometric analysis of research progress and prospects
doi 10.3389/fphar.2024.1409163
- 1,873 views
- 4 citations
REVIEW
Published on 03 Jul 2024
Breaking the barrier: Nanoparticle-enhanced radiotherapy as the new vanguard in brain tumor treatment
doi 10.3389/fphar.2024.1394816
- 1,286 views
- 4 citations
ORIGINAL RESEARCH
Published on 02 Jul 2024
Comparison of the diagnostic efficacy of systemic inflammatory indicators in the early diagnosis of ovarian cancer
doi 10.3389/fonc.2024.1381268
- 1,136 views
- 3 citations
ORIGINAL RESEARCH
Published on 09 Feb 2024
Effect of high-dose polymeric nanoparticle micellar paclitaxel on improved progression-free survival in patients with optimally resected stage III or IV high-grade carcinoma of the ovary: a prospective cohort study with historical controls
doi 10.3389/fonc.2024.1203129
- 844 views
- 2 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore